ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,629.00
0.00%
S&P ASX All Technology
3,016.30
0.00%
Brent Oil
82.765
0.00%
US Dollar vs AUD
1.51075
-0.22%
Bitcoin
63,670.53
-0.35%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. PMV Pharmaceuticals Inc (PMVP)

  7. PMV Pharmaceuticals Inc (PMVP) News

PMVP PMV Pharmaceuticals Inc

1.98
0.11 (5.88%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
PMV Pharmaceuticals Inc PMVP NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.11 5.88% 1.98 10:00:00
Open Price Low Price High Price Close Price Previous Close
1.92 1.89 2.0102 1.99 1.87
more quote information »

Recent News

Date Time Source Heading
27/3/202423:00GLOBEPMV Pharmaceuticals Announces First Patient Dosed in Global..
19/3/202407:01GLOBEPMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in..
01/3/202408:05EDGAR2Form 8-K - Current report
01/3/202408:01GLOBEPMV Pharmaceuticals Reports Full Year 2023 Financial Results..
27/2/202400:00GLOBEPMV Pharmaceuticals to Participate in the TD Cowen 44th..
25/1/202401:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
23/1/202408:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202408:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202408:02EDGAR2Form 8-K - Current report
19/1/202408:01GLOBEPMV Pharmaceuticals Announces Prioritization of PC14586..
12/1/202408:18EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/1/202408:01EDGAR2Form 8-K - Current report
06/1/202408:01GLOBEPMV Pharmaceuticals Strengthens Leadership with Key..
10/11/202300:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202300:00EDGAR2Form 8-K - Current report
10/11/202300:00GLOBEPMV Pharmaceuticals Reports Third Quarter 2023 Financial..
13/10/202308:02EDGAR2Form 8-K - Current report
13/10/202303:30GLOBEPMV Pharmaceuticals Updated PC14586 Phase 1 Data..
12/10/202307:02EDGAR2Form 8-K - Current report
12/10/202303:00GLOBEPMV Pharmaceuticals to Present Updated Phase 1 Data on..
21/9/202306:05GLOBEPMV Pharmaceuticals to Present Updated Phase 1 Data on..
19/9/202306:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202306:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:00EDGAR2Form 8-K - Current report
09/8/202322:00GLOBEPMV Pharmaceuticals Reports Second Quarter 2023 Financial..
07/6/202306:01GLOBEPMV Pharmaceuticals to Participate in the Goldman Sachs..
10/5/202322:00GLOBEPMV Pharmaceuticals Reports First Quarter 2023 Financial..

Your Recent History

NASDAQ
PMVP
PMV Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved